{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:00:52Z","timestamp":1791320452873,"version":"4.3.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.tracli.2014.03.005","type":"journal-article","created":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T09:03:06Z","timestamp":1399280586000},"page":"77-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Transfusion et dr\u00e9panocytose\u00a0: axes d\u2019optimisation de la s\u00e9curit\u00e9 transfusionnelle"],"prefix":"10.1016","volume":"21","author":[{"given":"F.","family":"Noizat-Pirenne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2014.03.005_bib0005","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood-2002-01-0229","article-title":"Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety","volume":"100","author":"Noizat-Pirenne","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2014.03.005_bib0010","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2011-11-327361","article-title":"Red cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management","volume":"120","author":"Yazdanbakhsh","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2014.03.005_bib0015","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/MOH.0b013e328313695e","article-title":"The role of inflammation in alloimmunization to antigens on transfused red blood cells","volume":"15","author":"Zimring","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.tracli.2014.03.005_bib0020","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.3324\/haematol.12074","article-title":"Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease","volume":"92","author":"Noizat-Pirenne","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.tracli.2014.03.005_bib0025","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/j.1537-2995.2009.02199.x","article-title":"Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death","volume":"49","author":"Chadebech","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2014.03.005_bib0030","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0197-2456(97)00099-8","article-title":"Stroke prevention trial in sickle cell anemia","volume":"19","author":"Adams","year":"1998","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.tracli.2014.03.005_bib0035","first-page":"285","article-title":"Promotion du don dans la population Afro-Antillaise d\u2019\u00cele-de-France et am\u00e9lioration de la ressource pour les patients dr\u00e9panocytaires","volume":"16","author":"Walch","year":"2009","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2014.03.005_bib0040","first-page":"280","article-title":"Trait dr\u00e9panocytaire et donneurs d\u2019origine afro-antillaise en \u00cele-de-France","volume":"16","author":"P\u00e9tapermal","year":"2009","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2014.03.005_bib0045","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-3148.2006.00661.x","article-title":"Red blood cells from donors with sickle cell trait: a safety issue for transfusion?","volume":"16","author":"Ould Amar","year":"2006","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2014.03.005_bib0050","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1537-2995.2008.01693.x","article-title":"Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review","volume":"48","author":"Win","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2014.03.005_bib0055","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.tracli.2011.09.001","article-title":"Relevance of RH variants in transfusion in sickle cell disease","volume":"18","author":"Noizat-Pirenne","year":"2011","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2014.03.005_bib0060","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2014.104703","article-title":"Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti-Rh linked to partial Rh phenotype","author":"Silvy","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.tracli.2014.03.005_bib0065","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tracli.2008.02.001","article-title":"The rare blood groups: a public health challenge","volume":"15","author":"Peyrard","year":"2008","journal-title":"Transfus Clin Biol"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782014000238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782014000238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:34:39Z","timestamp":1761129279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782014000238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S1246782014000238"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2014.03.005","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transfusion et dr\u00e9panocytose\u00a0: axes d\u2019optimisation de la s\u00e9curit\u00e9 transfusionnelle","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2014.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}